Skip to main content
. 2018 Feb 1;9(13):11258–11267. doi: 10.18632/oncotarget.24371

Figure 4.

Figure 4

Serum levels of (A) IL-4 and (B) IL-13 in patients with PV (n = 19) and healthy control subjects (n = 19), as detected by ELISA. In patients with PV, Nr4a2 expression correlated negatively with corresponding serum levels of (C) IL-4 and (D) IL-13. The Nr4a2 mRNA level was also negatively correlated with serum levels of (E) IL-4 and (F) IL-13. (*p < 0.05, **p < 0.01, ***p < 0.001).